Assigning a value to development-stage
biotech companies is a questionable task, and generally requires
more intangible assumptions (market potential, clinic...
1670
1
Jaehyung Yoon
08/13/09 11:20 PM
ARIA
Analysis
I think given the volatility and the
spotlight that biotech has received, this is a good company to
place a small amount of our hard-earned money for a specu...
2288
3
Copyright 2009 All Rights Reserved; Patent Pending
